| 國立臺灣大學 |
2013 |
EGFR polymorphisms, hormone replacement therapy and lung adenocarcinoma risk: analysis from a genome-wide association study in never-smoking women
|
Chen, Kuan-Yu; Hsiao, Chin-Fu; Chang, Gee-Chen; Tsai, Ying-Huang; Su, Wu-Chou; Chen, Yuh-Min; Huang, Ming-Shyan; Hsiung, Chao A.; Chen, Chien-Jen; Yang, Pan-Chyr; 陳建仁; 楊泮池; 陳冠宇 |
| 國立成功大學 |
2024-03-27 |
EGFR targeting PhosTACs as a dual inhibitory approach reveals differential downstream signaling
|
Hu;Zhenyi;Chen;Po-Han;Li;Wenxue;Krone;Mackenzie;Zheng;Sijin;Saarbach;Jacques;Velasco;Urquizo, Ines;Hines;John;Liu;Yansheng;Crews;Craig, M. |
| 國立交通大學 |
2020-10-05T02:01:09Z |
EGFR Tyrosine Kinase Inhibitor-Associated Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic
|
Chang, Hsu-Liang; Chen, Yen-Hsu; Taiwan, Hsin-Chu; Yang, Chih-Jen |
| 臺大學術典藏 |
2022-08-10T02:37:41Z |
EGFR tyrosine kinase inhibitors for EGFR mutation-positive non-small-cell lung cancer: Outcomes in Asian populations
|
Kim E.S.; Melosky B.; Park K.; Yamamoto N.; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T09:27:23Z |
EGFR tyrosine kinase inhibitors for the treatment of NSCLC in East Asia: present and future
|
Chih-Hsin Yang; CHIH-HSIN YANG |
| 國立成功大學 |
2002 |
EGFR tyrosine kinase 抑制劑單獨或合併抗癌化學藥物對人體膀胱癌細胞之毒殺與生長抑制之研究
|
蔡宗欣 |
| 國家衛生研究院 |
2013-04 |
EGFR variant III act as the major determinant factors in the EGFR/PI3K/AKT pathway for the survival outcome of oral cancer patients
|
Chang, KY;Tsai, SY;Chen, SH;Tsou, HH;Yen, CJ;Tang, CK;Yen, CY;Chang, JY |
| 國立成功大學 |
2013-04-15 |
EGFR variant III act as the major determinant factors in the EGFR/PI3K/AKT pathway for the survival outcome of oral cancer patients
|
Chang, Kwang-yu; Tsai, Shan-Yin; Chen, Shang-Hung; Tsou, Hsiao-Hui; Yen, Chia-Jui; Tang, Careen K.; Yen, Ching-Yu; Chang, Jang-Yang |
| 國立成功大學 |
2002 |
EGFR 的表現及其對血管新生的調控在胸腺瘤之研究
|
陳芬芬 |
| 高雄醫學大學 |
2006 |
EGFR(L858R) polymorphism frequency in Taiwan
|
Chen, Kuan-Hong;溫政浩;Hsu, Yin-Chin;張學偉 |
| 國家衛生研究院 |
2018-10 |
EGFR, SMAD7, and TGFBR2 polymorphisms are associated with colorectal cancer in patients with lynch syndrome
|
Kamiza, AB;Wang, WC;You, JF;Tang, R;Wang, YT;Chien, HT;Lai, CH;Chiu, LP;Lo, TP;Hung, KY;Hsiung, CA;Yeh, CC |
| 臺大學術典藏 |
2020-12-02T02:33:27Z |
EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma
|
Chen H.-Y.; Liu C.-H.; Chang Y.-H.; Yu S.-L.; Ho B.C.; Hsu C.-P.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Hsia J.-Y.; Chuang C.-Y.; Chang C.-S.; Li Y.-C.; Li K.-C.; Chang G.-C.; Pan-Chyr Yang; Chen H.-Y.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2021-03-03T08:35:09Z |
EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis
|
Wu N.-L.;Huang D.-Y.;Hsieh S.-L.;Hsiao C.-H.;Lee T.-A.;Wan-Wan Lin; Wu N.-L.; Huang D.-Y.; Hsieh S.-L.; Hsiao C.-H.; Lee T.-A.; WAN-WAN LIN |
| 國立臺灣大學 |
2015 |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
|
Tsai, Meng-Feng; Chang, Tzu-Hua; Wu, Shang-Gin; Yang, Hsiao-Yin; Hsu, Yi-Chiung; Yang, Pan-Chyr; Shih, Jin-Yuan; 楊泮池; 吳尚俊; 施金元 |
| 臺大學術典藏 |
2018-09-10T15:17:53Z |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
|
Tsai, Meng-Feng; Chang, Tzu-Hua; Wu, Shang-Gin; Yang, Hsiao-Yin; Hsu, Yi-Chiung; Yang, Pan-Chyr; Shih, Jin-Yuan; 楊泮池; JIN-YUAN SHIH; Yang, Pan-Chyr |
| 臺大學術典藏 |
2020-08-12T08:25:23Z |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
|
Shih J.-Y.; Tsai M.-F.; Chang T.-H.; SHANG-GIN WU; Yang H.-Y.; Hsu Y.-C.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:41Z |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
|
Yang P.-C.; Hsu Y.-C.; Tsai M.-F.; Chang T.-H.; Wu S.-G.; Yang H.-Y.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-12-02T02:33:29Z |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
|
Tsai M.-F.; Chang T.-H.; Wu S.-G.; Yang H.-Y.; Hsu Y.-C.; Pan-Chyr Yang; Shih J.-Y.; Tsai M.-F.; Chang T.-H.; Wu S.-G.; Yang H.-Y.; Hsu Y.-C.; PAN-CHYR YANG; Shih J.-Y. |
| 大葉大學 |
2015-09 |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway.
|
Tsai, Meng-Feng;TH, Chang;SG, Wu;HY, Yang;YC, Hsu;PC, Yang;JY, Shih |
| 臺大學術典藏 |
2019-11-08T03:21:46Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Chang, Chia-Ching; CHONG-JEN YU; PAN-CHYR YANG; CHAO-CHI HO; CHAO-CHI HO;PAN-CHYR YANG;CHONG-JEN YU;Chang, Chia-Ching;Lin, Shr-Uen;HUEI-WEN CHEN;Chen, Hsuan-Yu;SUNG-LIANG YU;Lin, Chih-An; Lin, Chih-An; SUNG-LIANG YU; Chen, Hsuan-Yu; HUEI-WEN CHEN; Lin, Shr-Uen |
| 臺大學術典藏 |
2020-06-17T03:01:28Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Lin C.-A.;Sung-Liang Yu;Chen H.-Y.;Chen H.-W.;Lin S.-U.;Chang C.-C.;Yu C.-J.;Yang P.-C.;Ho C.-C.; Lin C.-A.; SUNG-LIANG YU; Chen H.-Y.; Chen H.-W.; Lin S.-U.; Chang C.-C.; Yu C.-J.; Yang P.-C.; Ho C.-C. |
| 臺大學術典藏 |
2020-07-21T06:46:17Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Lin C.-A.; Yu S.-L.; Chen H.-Y.; Chen H.-W.; Lin S.-U.; Chang C.-C.; Yu C.-J.; Yang P.-C.; CHAO-CHI HO |
| 臺大學術典藏 |
2020-08-12T02:50:37Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Yu S.-L.; Lin C.-A.; Lin C.-A.;Yu S.-L.;Chen H.-Y.;Chen H.-W.;Lin S.-U.;Chang C.-C.;Yu C.-J.;Yang P.-C.;Chao-Chi Ho; Chen H.-Y.; Chen H.-W.; Lin S.-U.; Chang C.-C.; Yu C.-J.; Yang P.-C.; CHAO-CHI HO |
| 臺大學術典藏 |
2020-08-12T06:34:20Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Ho C.-C.; Yang P.-C.; CHONG-JEN YU; Chang C.-C.; Lin S.-U.; Chen H.-W.; Chen H.-Y.; Yu S.-L.; Lin C.-A.; Lin C.-A.;Yu S.-L.;Chen H.-Y.;Chen H.-W.;Lin S.-U.;Chang C.-C.;Chong-Jen Yu;Yang P.-C.;Ho C.-C. |
| 臺大學術典藏 |
2022-03-09T03:12:20Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Lin C.-A.; Yu S.-L.; Chen H.-Y.; HUEI-WEN CHEN; Lin S.-U.; Chang C.-C.; Yu C.-J.; Yang P.-C.; Ho C.-C. |
| 臺大學術典藏 |
2020-12-02T02:33:09Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Lin C.-A.;Yu S.-L.;Chen H.-Y.;Chen H.-W.;Lin S.-U.;Chang C.-C.;Yu C.-J.;Pan-Chyr Yang;Ho C.-C.; Lin C.-A.; Yu S.-L.; Chen H.-Y.; Chen H.-W.; Lin S.-U.; Chang C.-C.; Yu C.-J.; PAN-CHYR YANG; Ho C.-C. |
| 臺大學術典藏 |
2022-06-27T06:59:54Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Lin C.-A.; Yu S.-L.; Chen H.-Y.; Chen H.-W.; Lin S.-U.; Chang C.-C.; CHONG-JEN YU; Yang P.-C.; Ho C.-C. |
| 臺大學術典藏 |
2020-02-27T06:39:23Z |
EGFR-targeted micelles containing near-infrared dye for enhanced photothermal therapy in colorectal cancer
|
Shih Y.-H.;Luo T.-Y.;Chiang P.-F.;Yao C.-J.;Lin W.-J.;Peng C.-L.;Ming-Jium Shieh; Shih Y.-H.; Luo T.-Y.; Chiang P.-F.; Yao C.-J.; Lin W.-J.; Peng C.-L.; MING-JIUM SHIEH |
| 國立臺灣海洋大學 |
2018-02 |
EGFR-Targeted Photodynamic Therapy by Curcumin-Encapsulated Chitosan/TPP Nanoparticles
|
Wen-Hsuan Tsai; Kun-Hua Yu; Yi-Cheng Huang; Cheng-I Lee |
| 國立臺灣海洋大學 |
2017-12 |
EGFR-Targeted Photodynamic Therapy by Curcumin-Encapsulated Chitosan/TPP Nanoparticles.
|
Yi-Cheng Huang; Cheng-I Lee; Kun-Hua Yu; Wen-Hsuan Tsai |
| 臺大學術典藏 |
2020-02-27T06:39:28Z |
EGFR-targeting peptide conjugated ph-sensitive micelles as a potential drug carrier for photodynamic detection and therapy of cancer
|
Peng C.-L.;Chen Y.-I.;Shih Y.-H.;Luo T.-Y.;Ming-Jium Shieh; Peng C.-L.; Chen Y.-I.; Shih Y.-H.; Luo T.-Y.; MING-JIUM SHIEH |
| 國立成功大學 |
2021-09 |
EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis
|
Tsai;Jeng-Shiuan;Su;Po-Lan;Yang;Szu-Chun;Chang;Chao-Chun;Lin;Chia-Ying;Yen;Yi-Ting;Tseng;Yau-Lin;Lai;Wu-Wei;Lin;Chien-Chung;Su;Wu-Chou |
| 國立交通大學 |
2018-01-24T07:39:25Z |
EGFR-TKI小分子標靶藥物治療非小細胞肺癌之細胞反應與藥物交互作用
|
王祥宇; 曾慶平; 徐祖安; Wang, Hsian-Yu; Tseng, Ching-Ping; Hsu, John T. -A. |
| 中國醫藥大學 |
2008-06-30 |
EGFR/JNK訊息路徑當作前列腺癌骨骼轉移治療標的研究
|
魏宗德(Tzong-Der Way) |
| 中國醫藥大學 |
2013-09 |
EGFR/SGLT1Interaction Does Not Respond to EGFR Modulators, But Inhibition of SGLT1 Sensitizes Prostate Cancer Cells to EGFR Tyrosine Kinase Inhibitors
|
(Jiangong Ren);(Lakshmi R. Bollu);(Fei Su);(Guang Gao);(Lei Xu);黃偉謙(Wei-Chien Huang);洪明奇(Mien-Chie Hung);(Zhang Weihua) |
| 國家衛生研究院 |
2025-08 |
EGFRvIII-driven microenvironmental fibroblast activation and transformation accelerate oral cancer progression via lipocalin-2/ STAT3 axis
|
Peng, HY;Chang, KY;Chang, WM;Wu, CY;Lee, HL;Chang, YC;Liu, KJ;Shiah, SG;Kuo, CC;Chang, JY |
| 中國醫藥大學 |
2013-02-28 |
EGFR和MPO基因多型性與菸酒檳榔對罹患口腔癌前病變的交互作用
|
李郁芬(Yu-Fen Li) |
| 中山醫學大學 |
2016-07-01 |
EGFR基因是否有突變之辨識系統使用肺腺癌CT影像
|
昝亭甄 |
| 國家衛生研究院 |
2023 |
EGFR對癌細胞三維堆疊的空間效益
|
董國忠 |
| 國家衛生研究院 |
2011 |
EGFR抑制劑之藥物最佳化
|
謝興邦 |
| 國家衛生研究院 |
2008 |
EGFR抑制劑之藥物最佳化
|
謝興邦 |
| 國家衛生研究院 |
2009 |
EGFR抑制劑之藥物最佳化
|
謝興邦 |
| 國家衛生研究院 |
2010 |
EGFR抑制劑之藥物最佳化
|
謝興邦 |
| 國家衛生研究院 |
2008 |
EGFR於肺癌進展過程中於細胞生長及microRNA的調節之研究
|
吳成文 |
| 中國醫藥大學 |
2013-12-08 |
EGFR突變型的過度表現經由活化TENASCIN-C增加頭頸部鱗狀上皮癌細胞的侵犯力與降低癌瘲病人存活率
|
蔡銘修(Ming-Hsui Tsai);詹佳穎(Chia-Ing Jan);韓鴻志(Horng-Jyh Harn);黃偉謙(Wei-Chien Huang);洪明奇(Mien-Chie Hung) |
| 淡江大學 |
2013 |
EGFR與HER2抑制劑之間接與直接藥物設計
|
張庭瑜; Chang, Ting-Yu |
| 中國醫藥大學 |
2014-07-31 |
EGFR訊息傳遞與癌細胞代謝調控之交互作用探討－葡萄糖吸收與內質網壓力影響EGFR TKIs 抗癌效果之角色探討(1/3)
|
黃偉謙(Wei-Chien Huang) |
| 中國醫藥大學 |
2015-07-31 |
EGFR訊息傳遞與癌細胞代謝調控之交互作用探討－葡萄糖吸收與內質網壓力影響EGFR TKIs 抗癌效果之角色探討(2/3)
|
黃偉謙(Wei-Chien Huang) |
| 國立成功大學 |
2020-08-22 |
EGF誘發非小細胞肺癌中發炎因子PTX3的敏感性
|
林佩瑩; Lin, Pei-Ying |
| 國立成功大學 |
2020-07-08 |
EGF誘發非小細胞肺癌中發炎因子PTX3的敏感性
|
林佩瑩; Lin, Pei-Ying |
